Shared Decision-Making in Optimal Care of Psoriasis and Digital Tools: Making It Work in PracticePremiere Date: Thursday, February 14, 2019
This activity offers CE credit for:%>
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Friday, February 14, 2020
|Joel M. Gelfand, MD, MSCE (Moderator)
Professor of Dermatology and of Epidemiology
Vice Chair of Clinical Research
Medical Director, Dermatology Clinical Studies Unit
Director, Psoriasis and Phototherapy Treatment Center
University of Pennsylvania Perelman School of Medicine
|B. Jang Mi Johnson, PA-C
Diplomate, Society of Dermatology Physician Assistants
Senior Delegate to the AAPA House of Delegates
Past President, Illinois Society of Dermatology Physician Assistants
Past Sergeant-at-Arms, American Academy of Physician Assistants
Senior Physician Assistant-Certified, Illinois Dermatology Institute
|Junko Takeshita, MD, PhD, MSCE
Assistant Professor of Dermatology
Assistant Professor of Epidemiology
University of Pennsylvania Perelman School of Medicine
Psoriasis is a systemic inflammatory disease associated with a host of comorbid conditions. Unfortunately, the condition often remains untreated or undertreated despite its prevalence and the availability of many treatments. Suboptimal outcomes and poor patient satisfaction are often caused by the use of mere topical agents to treat moderate and severe psoriasis when more potent biologic and oral treatments should be used.
Effective communication with patients is essential to determine treatment goals and then select appropriate treatment. Additionally, health care coaches have been shown to improve outcomes in patients with chronic conditions, and supplemental education to patients is the best method of ensuring that they are armed with all the necessary tools to attack their psoriasis and prevent it from controlling their lives.
In this CME Outfitters Live and On Demand, expert faculty will discuss how best to include digital health coaching into clinical practice to reinforce patient education and provide critical guidance to patients.
At the end of this CE activity, participants should be able to:
- Ensure management of comorbid conditions in patients with psoriasis through screening and appropriate referral when necessary.
- Employ a proactive approach to the management of patients with moderate-to-severe psoriasis not responding to current treatments.
- Integrate digital coaching into the management of patients with psoriasis to improve patient outcomes and treatment satisfaction.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Explain management of comorbid conditions in patients with psoriasis through screening and appropriate referral when necessary.
- Describe a proactive approach to the management of patients with moderate-to-severe psoriasis not responding to current treatments.
- Identify digital coaching tools for the management of patients with psoriasis to improve patient outcomes and treatment satisfaction.
Supported by educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.
Dermatologists, physician assistants, nurse practitioners, nurses, and pharmacists.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gelfand reports that he receives grants from AbbVie Inc.; Boehringer Ingelheim; Celgene Corporation; Janssen Biologics, Inc.; Novartis Corporation; Ortho Dermatologics; and Pfizer Inc. He is a consultant for Boehringer Ingelheim; Bristol-Myers Squibb Company; Janssen Biologics, Inc.; NeuroDerm Data and Safety Monitoring Board (DSMB); Novartis Corporation; Pfizer Inc.; Sun Pharmaceutical Industries; and UCB Data and Safety Monitoring Board (DSMB). He receives other financial or material support as a Co-patent holder of resiquimod for treatment of cutaneous T-cell lymphoma; and Deputy Editor for the Journal of Investigative Dermatology, receiving honoraria from the Society for Investigative Dermatology.
B. Jang Mi Johnson, PA-C has no disclosures to report.
Dr. Takeshita reports that she receives research grants (to the Trustees of the University of Pennsylvania) from Pfizer Inc.
Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Kate Nelson, PhD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).